Tivic Health Systems, Inc.(TIVC)Earnings, Financials & Key Ratios
TIVC•NASDAQ
$1.01
$3M mkt cap·Price updated May 6, 2026
AboutTivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.Show more
- Revenue$780K-33.7%
- EBITDA-$5M+34.2%
- Net Income-$6M+31.4%
- EPS (Diluted)-19.67+88.9%
- Gross Margin0.26%-98.9%
- EBITDA Margin-680.64%+0.7%
- Operating Margin-725.77%-3.5%
- Net Margin-725%-3.4%
- ROE-184.96%+19.1%
- ROIC-781.19%+24.4%
TIVC Key Insights
Tivic Health Systems, Inc. (TIVC) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y sales CAGR of 13.2%
✗Weaknesses
- ✗Weak Piotroski F-Score: 3/9
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 14 (bottom 14%)
- ✗Shares diluted 100.0% in last year
- ✗Trading more than 30% below 52-week high
- ✗Expensive at 114.5x book value
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
TIVC Price & Volume
Tivic Health Systems, Inc. (TIVC) stock price & volume — 10-year historical chart
Loading chart...
TIVC Growth Metrics
Tivic Health Systems, Inc. (TIVC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years13.18%
3 Years-12.54%
TTM-49.63%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-16.9%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM81.12%
Return on Capital
10 Years-163.15%
5 Years-165.05%
3 Years-167.09%
Last Year-179.97%
TIVC Recent Earnings
Tivic Health Systems, Inc. (TIVC) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 7/12 qtrs (78%)●Beat Revenue 0/12 qtrs (0%)
Q4 2025Latest
Nov 14, 2025EPS
$1.97
Revenue
$146,000
Q3 2025
Aug 14, 2025EPS
$2.19
Revenue
$86,000
Q2 2025
May 15, 2025EPS
$2.52
Revenue
$70,000
Q2 2025
Mar 21, 2025EPS
$15.42
Est $85.00
+81.9%
Revenue
$180,000
Est $1M
-87.4%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q4 2025Latest | Nov 14, 2025 | $1.97 | $146,000 |
| Q3 2025 | Aug 14, 2025 | $2.19 | $86,000 |
| Q2 2025 | May 15, 2025 | $2.52 | $70,000 |
| Q2 2025 | Mar 21, 2025 | $15.42vs $85.00+81.9% | $180,000vs $1M-87.4% |
Based on last 12 quarters of dataView full earnings history →
TIVC Peer Comparison
Tivic Health Systems, Inc. (TIVC) competitors in Neuromodulation and neuro devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ELMD | 214.77M | 25.94 | 30.16 | 16.97% | 13.06% | 19.79% | 0.00 | |
 STIM | 132.9M | 1.91 | -3.24 | 99.17% | -24.48% | -139.83% | 3.44 | |
 GKOS | 7.92B | 135.27 | -41.24 | 32.33% | -34.34% | -26.46% | 0.21 | |
 LIVN | 3.62B | 66.26 | -14.89 | 10.74% | 7.47% | 9.13% | 0.39 | |
 NVCR | 1.88B | 16.50 | -13.52 | 8.28% | -25.66% | -50.82% | 0.85 | |
 ENVA | 4.3B | 172.57 | 14.90 | 18.58% | 24.88% | 3.41 | ||
 SGMO | 37.8M | 0.18 | -0.36 | -67.2% | -331.28% | -8.14% | 1.34 | |
 MDT | 99.48B | 77.60 | 21.50 | 3.62% | 13% | 9.45% | 0.59 |
Compare TIVC vs Peers
Tivic Health Systems, Inc. (TIVC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
TIVC Income Statement
Tivic Health Systems, Inc. (TIVC) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|
| Sales/Revenue | 420K | 860K | 1.17M | 1.84M | 1.18M | 780K | 482K |
| Revenue Growth % | - | 104.76% | 35.58% | 57.8% | -36.09% | -33.67% | -49.63% |
| Cost of Goods Sold | 709K | 1.08M | 1.29M | 1.54M | 889K | 778K | 762K |
| COGS % of Revenue | 168.81% | 126.16% | 111.06% | 83.75% | 75.6% | 99.74% | - |
| Gross Profit | -289K▲ 0% | -225K▲ 22.1% | -129K▲ 42.7% | 299K▲ 331.8% | 287K▼ 4.0% | 2K▼ 99.3% | -280K▲ 0% |
| Gross Margin % | -68.81% | -26.16% | -11.06% | 16.25% | 24.4% | 0.26% | -58.09% |
| Gross Profit Growth % | - | 22.15% | 42.67% | 331.78% | -4.01% | -99.3% | - |
| Operating Expenses | 3.35M | 2.98M | 5.5M | 10.4M | 8.53M | 5.66M | 7.19M |
| OpEx % of Revenue | 798.57% | 346.4% | 471.96% | 565.05% | 725.51% | 726.03% | - |
| Selling, General & Admin | 2.36M | 2.32M | 4.63M | 8.67M | 6.88M | 4.35M | 5M |
| SG&A % of Revenue | 562.86% | 269.77% | 396.66% | 471.03% | 584.78% | 557.69% | - |
| Research & Development | 990K | 659K | 878K | 1.73M | 1.66M | 1.31M | 2.18M |
| R&D % of Revenue | 235.71% | 76.63% | 75.3% | 94.02% | 140.73% | 168.33% | - |
| Other Operating Expenses | 15K | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.64M▲ 0% | -3.2M▲ 12.1% | -5.63M▼ 75.8% | -10.1M▼ 79.3% | -8.24M▲ 18.4% | -5.66M▲ 31.3% | -7.47M▲ 0% |
| Operating Margin % | -867.38% | -372.56% | -483.02% | -548.8% | -701.11% | -725.77% | -1548.96% |
| Operating Income Growth % | - | 12.05% | -75.78% | -79.3% | 18.35% | 31.34% | - |
| EBITDA | -3.64M | -3.2M | -5.61M | -9.92M | -8.06M | -5.31M | -7.3M |
| EBITDA Margin % | -866.43% | -371.63% | -480.96% | -539.35% | -685.63% | -680.64% | -1515.35% |
| EBITDA Growth % | - | 12.17% | -75.47% | -76.96% | 18.75% | 34.16% | -17.13% |
| D&A (Non-Cash Add-back) | 4K | 8K | 24K | 174K | 182K | 352K | 275K |
| EBIT | -3.7M | -3.22M | -6.67M | -10.1M | -8.24M | -5.66M | -7.58M |
| Net Interest Income | -443K | -423K | -1.82M | 2K | 1K | 6K | 17K |
| Interest Income | 0 | 0 | 0 | 2K | 1K | 6K | 17K |
| Interest Expense | 443K | 423K | 1.82M | 0 | 0 | 0 | 0 |
| Other Income/Expense | -503K | -435K | -2.86M | 2K | 999 | 6K | -40K |
| Pretax Income | -4.15M▲ 0% | -3.64M▲ 12.2% | -8.49M▼ 133.4% | -10.1M▼ 18.9% | -8.24M▲ 18.3% | -5.66M▲ 31.4% | -7.51M▲ 0% |
| Pretax Margin % | -987.14% | -423.14% | -728.39% | -548.7% | -701.02% | -725% | -1557.26% |
| Income Tax | 2K | 0 | 1K | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | -0.05% | 0% | -0.01% | 0% | 0% | 0% | 0% |
| Net Income | -4.15M▲ 0% | -3.64M▲ 12.3% | -8.49M▼ 133.4% | -10.1M▼ 18.9% | -8.24M▲ 18.3% | -5.66M▲ 31.4% | -7.51M▲ 0% |
| Net Margin % | -987.62% | -423.14% | -728.47% | -548.7% | -701.02% | -725% | -1557.26% |
| Net Income Growth % | - | 12.27% | -133.42% | -18.86% | 18.34% | 31.4% | -16.9% |
| Net Income (Continuing) | -4.15M | -3.64M | -8.49M | -10.1M | -8.24M | -5.66M | -7.51M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -180.35▲ 0% | -177.01▲ 1.9% | -243.15▼ 37.4% | -104.37▲ 57.1% | -176.72▼ 69.3% | -19.67▲ 88.9% | -5.68▲ 0% |
| EPS Growth % | - | 1.85% | -37.37% | 57.08% | -69.32% | 88.87% | 81.12% |
| EPS (Basic) | -180.36 | -177.01 | -243.16 | -104.37 | -176.72 | -19.67 | - |
| Diluted Shares Outstanding | 23K | 23.03K | 34.93K | 96.73K | 46.65K | 287.37M | 1.32M |
| Basic Shares Outstanding | 23K | 23.03K | 34.93K | 96.73K | 46.65K | 287.37M | 1.32M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |
TIVC Balance Sheet
Tivic Health Systems, Inc. (TIVC) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|
| Total Current Assets | 2.97M | 1.5M | 14.29M | 4.72M | 4.65M | 2.64M | 3.74M |
| Cash & Short-Term Investments | 2.31M | 1.04M | 12.97M | 3.52M | 3.4M | 2M | 3.45M |
| Cash Only | 2.31M | 1.04M | 12.97M | 3.52M | 3.4M | 2M | 3.45M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 13K | 52K | 92K | 107K | 174K | 69K | 19K |
| Days Sales Outstanding | 11.3 | 22.07 | 28.8 | 21.23 | 54.01 | 32.29 | 21.58 |
| Inventory | 475K | 241K | 429K | 863K | 756K | 319K | 4K |
| Days Inventory Outstanding | 244.53 | 81.07 | 120.92 | 204.41 | 310.39 | 149.66 | 109.21 |
| Other Current Assets | 0 | 160K | -41K | 235K | 327K | 249K | 267K |
| Total Non-Current Assets | 50K | 34K | 747K | 1.3M | 505K | 168K | 2.49M |
| Property, Plant & Equipment | 27K | 19K | 698K | 535K | 471K | 119K | 12K |
| Fixed Asset Turnover | 15.56x | 45.26x | 1.67x | 3.44x | 2.50x | 6.55x | 5.22x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 23K | 15K | 49K | 618K | 34K | 49K | 3M |
| Total Assets | 3.02M▲ 0% | 1.53M▼ 49.4% | 15.04M▲ 882.1% | 6.02M▼ 60.0% | 5.16M▼ 14.3% | 2.81M▼ 45.6% | 6.23M▲ 0% |
| Asset Turnover | 0.14x | 0.56x | 0.08x | 0.31x | 0.23x | 0.28x | 0.11x |
| Asset Growth % | - | -49.37% | 882.1% | -59.98% | -14.31% | -45.57% | 46.15% |
| Total Current Liabilities | 653K | 1.27M | 1.22M | 1.88M | 1.4M | 272K | 638K |
| Accounts Payable | 369K | 370K | 789K | 1.32M | 713K | 125K | 465K |
| Days Payables Outstanding | 189.96 | 124.47 | 222.38 | 313.36 | 292.74 | 58.64 | 151.13 |
| Short-Term Debt | 0 | 36K | 0 | 163K | 0 | 0 | 0 |
| Deferred Revenue (Current) | 1K | 16K | 0 | 2K | 0 | 0 | 0 |
| Other Current Liabilities | 1K | 853K | 0 | 245K | 277K | 0 | 173K |
| Current Ratio | 4.55x | 1.17x | 11.72x | 2.51x | 3.32x | 9.70x | 9.70x |
| Quick Ratio | 3.83x | 0.99x | 11.37x | 2.05x | 2.78x | 8.53x | 8.53x |
| Cash Conversion Cycle | 65.87 | -21.33 | -72.67 | -87.73 | 71.66 | 123.3 | -20.33 |
| Total Non-Current Liabilities | 0 | 1.43M | 545K | 510K | 176K | 0 | 0 |
| Long-Term Debt | 0 | 1.43M | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 545K | 367K | 176K | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 143K | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 653K | 2.71M | 1.76M | 2.39M | 1.58M | 272K | 638K |
| Total Debt | 0 | 1.47M | 708K | 530K | 369K | 0 | 0 |
| Net Debt | -2.31M | 425K | -12.27M | -2.99M | -3.03M | -2M | -3.45M |
| Debt / Equity | - | - | 0.05x | 0.15x | 0.10x | - | 0.00x |
| Debt / EBITDA | - | - | - | - | - | - | -0.00x |
| Net Debt / EBITDA | - | - | - | - | - | - | 0.47x |
| Interest Coverage | -8.22x | -7.57x | -3.09x | - | - | - | - |
| Total Equity | 2.37M▲ 0% | -1.18M▼ 149.6% | 13.27M▲ 1227.6% | 3.63M▼ 72.6% | 3.58M▼ 1.4% | 2.54M▼ 29.2% | 5.59M▲ 0% |
| Equity Growth % | - | -149.64% | 1227.61% | -72.65% | -1.38% | -29.19% | 97.06% |
| Book Value per Share | 103.09 | -51.10 | 379.93 | 37.53 | 76.74 | 0.01 | 4.23 |
| Total Shareholders' Equity | 2.37M | -1.18M | 13.27M | 3.63M | 3.58M | 2.54M | 5.59M |
| Common Stock | 1K | 1K | 1K | 1K | 0 | 1K | 2K |
| Retained Earnings | -7.41M | -11.05M | -19.55M | -29.64M | -37.89M | -43.54M | -49.62M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1K | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
TIVC Cash Flow Statement
Tivic Health Systems, Inc. (TIVC) cash flow — operating, investing & free cash flow history
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|
| Cash from Operations | -3.67M | -3.03M | -5.61M | -8.92M | -8.51M | -5.72M | -5.72M |
| Operating CF Margin % | -873.81% | -351.98% | -481.3% | -484.73% | -723.72% | -733.97% | - |
| Operating CF Growth % | - | 17.52% | -85.4% | -58.93% | 4.57% | 32.73% | -14.13% |
| Net Income | -4.15M | -3.64M | -8.49M | -10.1M | -8.24M | -5.66M | -7.51M |
| Depreciation & Amortization | 4K | 8K | 24K | 174K | 182K | 352K | 275K |
| Stock-Based Compensation | 10K | 78K | 57K | 398K | 271K | 229K | 478K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 532K | 482K | 3.2M | 0 | 32K | 354K | 773K |
| Working Capital Changes | -68K | 44K | -403K | 605K | -752K | -1M | -97K |
| Change in Receivables | -26K | -75K | -66K | 1K | -67K | 105K | -5K |
| Change in Inventory | -476K | 227K | -181K | -434K | 75K | 83K | 159K |
| Change in Payables | 348K | 1K | 419K | 534K | -610K | -588K | 132K |
| Cash from Investing | -31K | 0 | 0 | -11K | -118K | 0 | -556K |
| Capital Expenditures | -31K | 0 | 0 | -11K | -118K | 0 | -556K |
| CapEx % of Revenue | 7.38% | - | - | 0.6% | 10.03% | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 5.55M | 1.76M | 17.54M | -528K | 8.51M | 4.33M | 7.89M |
| Debt Issued (Net) | 1.71M | 1.75M | 2.59M | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 1000K | 10K | 1000K | -528K | 1000K | 1000K | 3.08M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 3K | 62K | 0 | 0 | -49K | 63K |
| Net Change in Cash | 1.85M▲ 0% | -1.27M▼ 168.4% | 11.93M▲ 1041.7% | -9.46M▼ 179.3% | -122K▲ 98.7% | -1.39M▼ 1041.8% | 1.26M▲ 0% |
| Free Cash Flow | -3.7M▲ 0% | -3.03M▲ 18.2% | -5.61M▼ 85.4% | -8.93M▼ 59.1% | -8.63M▲ 3.4% | -5.72M▲ 33.7% | -6.11M▲ 0% |
| FCF Margin % | -881.19% | -351.98% | -481.3% | -485.33% | -733.76% | -733.97% | -1267.01% |
| FCF Growth % | - | 18.21% | -85.4% | -59.12% | 3.37% | 33.65% | 0.44% |
| FCF per Share | -160.91 | -131.43 | -160.65 | -92.32 | -184.97 | -0.02 | -0.02 |
| FCF Conversion (FCF/Net Income) | 0.88x | 0.83x | 0.66x | 0.88x | 1.03x | 1.01x | 0.81x |
| Interest Paid | 0 | 1K | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 2K | 1K | 1K | 0 | 0 | 0 | 0 |
TIVC Key Ratios
Tivic Health Systems, Inc. (TIVC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -609.55% | -140.45% | -119.47% | -228.68% | -184.96% | -202.2% |
| Return on Invested Capital (ROIC) | - | -3339.13% | -919.11% | -1033.21% | -781.19% | -781.19% |
| Gross Margin | -26.16% | -11.06% | 16.25% | 24.4% | 0.26% | -58.09% |
| Net Margin | -423.14% | -728.47% | -548.7% | -701.02% | -725% | -1557.26% |
| Debt / Equity | - | 0.05x | 0.15x | 0.10x | - | 0.00x |
| Interest Coverage | -7.57x | -3.09x | - | - | - | - |
| FCF Conversion | 0.83x | 0.66x | 0.88x | 1.03x | 1.01x | 0.81x |
| Revenue Growth | 104.76% | 35.58% | 57.8% | -36.09% | -33.67% | -49.63% |
TIVC Frequently Asked Questions
Tivic Health Systems, Inc. (TIVC) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Tivic Health Systems, Inc. (TIVC) reported $0.5M in revenue for fiscal year 2024. This represents a 15% increase from $0.4M in 2019.
Tivic Health Systems, Inc. (TIVC) saw revenue decline by 33.7% over the past year.
Tivic Health Systems, Inc. (TIVC) reported a net loss of $7.5M for fiscal year 2024.
Dividend & Returns
Tivic Health Systems, Inc. (TIVC) has a return on equity (ROE) of -185.0%. Negative ROE indicates the company is unprofitable.
Tivic Health Systems, Inc. (TIVC) had negative free cash flow of $6.1M in fiscal year 2024, likely due to heavy capital investments.
Explore More TIVC
Tivic Health Systems, Inc. (TIVC) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates